FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

32976011000001104: Lonsurf 20mg/8.19mg tablets (Servier Laboratories Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 17-Aug 2016. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
100467501000001117 Lonsurf 20mg/8.19mg tablets (Servier Laboratories Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
100467601000001118 Lonsurf 20mg/8.19mg tablets (Servier Laboratories Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Lonsurf 20mg/8.19mg tablets (Servier Laboratories Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Lonsurf 20mg/8.19mg tablets (Servier Laboratories Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Lonsurf 20mg/8.19mg tablets (Servier Laboratories Ltd) Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator EMA (European Medicines Agency) monitoring false Inferred relationship Existential restriction modifier
Lonsurf 20mg/8.19mg tablets (Servier Laboratories Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Lonsurf 20mg/8.19mg tablets (Servier Laboratories Ltd) Is a Trifluridine 20mg / Tipiracil 8.19mg tablets true Inferred relationship Existential restriction modifier
Lonsurf 20mg/8.19mg tablets (Servier Laboratories Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Lonsurf 20mg/8.19mg tablets (Servier Laboratories Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Lonsurf 20mg/8.19mg tablets (Servier Laboratories Ltd) Has specific active ingredient Trifluridine true Inferred relationship Existential restriction modifier
Lonsurf 20mg/8.19mg tablets (Servier Laboratories Ltd) Has specific active ingredient Tipiracil hydrochloride false Inferred relationship Existential restriction modifier
Lonsurf 20mg/8.19mg tablets (Servier Laboratories Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Lonsurf 20mg/8.19mg tablets (Servier Laboratories Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Tipiracil false Inferred relationship Existential restriction modifier
Lonsurf 20mg/8.19mg tablets (Servier Laboratories Ltd) Has excipient Lactose false Inferred relationship Existential restriction modifier
Lonsurf 20mg/8.19mg tablets (Servier Laboratories Ltd) Is a Lonsurf true Inferred relationship Existential restriction modifier
Lonsurf 20mg/8.19mg tablets (Servier Laboratories Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Lonsurf 20mg/8.19mg tablets (Servier Laboratories Ltd) Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier
Lonsurf 20mg/8.19mg tablets (Servier Laboratories Ltd) Has specific active ingredient Tipiracil hydrochloride true Inferred relationship Existential restriction modifier
Lonsurf 20mg/8.19mg tablets (Servier Laboratories Ltd) Has basis of strength substance Tipiracil true Inferred relationship Existential restriction modifier
Lonsurf 20mg/8.19mg tablets (Servier Laboratories Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Tipiracil true Inferred relationship Existential restriction modifier
Lonsurf 20mg/8.19mg tablets (Servier Laboratories Ltd) Has active ingredient Antimetabolite true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Lonsurf 20mg/8.19mg tablets (Servier Laboratories Ltd) 20 tablet 2 x 10 tablets Has AMP True Lonsurf 20mg/8.19mg tablets (Servier Laboratories Ltd) Inferred relationship Existential restriction modifier
Lonsurf 20mg/8.19mg tablets (Servier Laboratories Ltd) 60 tablet 6 x 10 tablets Has AMP True Lonsurf 20mg/8.19mg tablets (Servier Laboratories Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start